Biofuel/renewable chemical makers Gevo (GEVO +4.4%) and Solazyme (SZYM +3.4%) rally after Canaccord starts coverage with Buy ratings (I, II). Canaccord sees Gevo ramping production of its chemicals over the next 12 months, and thinks a resolution of BP and DuPont's lawsuit would be a positive. Solazyme, meanwhile, is praised for its ability to produce "tailored oils" addressing huge market opportunities.
Biofuel/renewable chemical makers Gevo (GEVO +4.4%) and Solazyme (SZYM +3.4%) rally after...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs